{"name":"Azienda Ospedaliero-Universitaria Careggi","slug":"azienda-ospedaliero-universitaria-careggi","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPVkg2UnJZNm1hSjY3ZTU3WC04UkdEb2ROWGs2cFAtOUNDRExray13MWh5OGt2YlJnNWRfczhxRkdHVFJyNlpxXzBTVFFyZXduak13MElzODJMU2FheTB6WFg0LWJRWWJYa0N2TGVwSlNraFlqYmp1VXF0UVBKV0ZtSVZRd29Vd1piT3JDUHBiMVo4MWZa?oc=5","date":"2022-04-29","type":"regulatory","source":"TCTMD.com","summary":"FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy - TCTMD.com","headline":"FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxY2hEZDRkOFdzMlJDaGh0WGtHVkhrTktSNzBVVDVxaGhnVWdOLXRPMVlOcjd0ZkhhV2hOQXVuWmpUWGJTSDE1R09HMWthLTBJU0kxRm5SRl8zOVRaQUx3?oc=5","date":"2021-06-15","type":"pipeline","source":"Nature","summary":"Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis - Nature","headline":"Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with ana","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}